Galanthamine Hydrobromide

본문 바로가기


Home > Product > Galanthamine Hydrobromide
Selling leads
Galanthamine Hydrobromide
Posting date : Dec 24, 2010
Membership
Free Member Scince Dec 24, 2010
Package
25kg net weight cardboard with plastic inner
Keyword :
Category
Contact
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
HS-CODE
30-
Package & Delivery Lead Time
Package
25kg net weight cardboard with plastic inner
Delivery Lead Time
Detailed Description
Galanthamine Hydrobromide Original Plant:Shorttube Lycoris Specification:99% Synonym(s) :Reminyl, Nivalin Chemical Name:(4aS,6R,8aS)-6-Hydroxy-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzofuro[3a,3,2-e,f][2]benzazepine hydrobromide Test Method:HPLC Molecular Formula:C17H21NO3.HBr;C17H22BrNO3 Molecular Weight:368.27 CAS No.: 1953-04-4 EINECS No.: 217-780-5 Melting Point : 258~264 ℃ Solubility: Soluble in water,and slightly in alcohol. Appearance: White to whitish crystal powder, oderless and tasteless. Pharmacology Action: Galanthamine extract is specific, competitive and reversible acetylcholinesterase inhibitor. It is also an allosteric modulator at nicotinic cholinergic receptor sites potentiating cholinergic nicotinic neurotransmission. Both the acetylcholine and nicotine receptors have been suggested as areas related to cognitive impairment. Initially, Galanthamine extract was used in anesthesiology to antagonize the effects of non-depolarizing muscle relaxants, and since then it was rapidly introduced in other areas of medicine, i.e. neurology, ophthalmology, gastroenterology, intensive care and resuscitation, cardiology, physiotherapy. Galanthamine extract is a product with broad therapeutic index, allowing "soft" manifestation of its effect with individual dosing depending on the particular case. Several trials already showed that Galantamine 16 and 24 mg/day significantly benefits the cognitive, functional, and behavioral symptoms of AD as compared with placebo and proved also to be very effective in symptomatic treatment of senile dementia of Alzheimer's type.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top